Cessation of Animal Neurovirulence Testing for Novel OPV2: A Review of Supporting Evidence with Supplemental Analyses

Animal neurovirulence tests have historically been required for release of live oral polio vaccine virus seeds and monovalent bulks (which are intermediates in the production of vaccine lots) because of the demonstrated instability of attenuated phenotype. The improvement in knowledge about the genetics of attenuation, the development and application of high-throughput sequencing, and the advancement of vaccine strains genetically engineered to improve the stability of attenuated phenotype allows this requirement to be revisited considering the latest OPV Technical Report Series guidance from the World Health Organization. This review summarizes evidence from published literature and provides incremental results and analyses which collectively support the position that routine animal neurovirulence testing on novel type 2 oral polio vaccines should not be required. That is, the test does not contribute meaningfully to ensuring the safety of the vaccine when a validated, whole-genome high-throughput sequencing method is included in lot release and other standard production controls are in place. Evidence summarized and evaluated includes pre-clinical research studies, results from clinical research, genetic characterization from surveillance accompanying real-world usage, and characterization of manufacturing vaccine seeds and lots.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-18
DOI
https://doi.org/10.20944/preprints202611.1798.v1
Primary Topic
Viral Infections and Immunology Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Cessation of Animal Neurovirulence Testing for Novel OPV2: A Review of Supporting Evidence with Supplemental Analyses

Macadam Andrew, Kutub Mahmood, John Konz, Christopher Gast et al.
Preprints.org
Viral Infections and Immunology Research
preprint

Cessation of Animal Neurovirulence Testing for Novel OPV2: A Review of Supporting Evidence with Supplemental Analyses

Macadam Andrew, Kutub Mahmood, John Konz, Christopher Gast, Konstantin Chumakov, Javier Martin, Tong Wu, David Robinson
preprint en

Abstract

Animal neurovirulence tests have historically been required for release of live oral polio vaccine virus seeds and monovalent bulks (which are intermediates in the production of vaccine lots) because of the demonstrated instability of attenuated phenotype. The improvement in knowledge about the genetics of attenuation, the development and application of high-throughput sequencing, and the advancement of vaccine strains genetically engineered to improve the stability of attenuated phenotype allows this requirement to be revisited considering the latest OPV Technical Report Series guidance from the World Health Organization. This review summarizes evidence from published literature and provides incremental results and analyses which collectively support the position that routine animal neurovirulence testing on novel type 2 oral polio vaccines should not be required. That is, the test does not contribute meaningfully to ensuring the safety of the vaccine when a validated, whole-genome high-throughput sequencing method is included in lot release and other standard production controls are in place. Evidence summarized and evaluated includes pre-clinical research studies, results from clinical research, genetic characterization from surveillance accompanying real-world usage, and characterization of manufacturing vaccine seeds and lots.

Preprints.org
Viral Infections and Immunology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon